Ca-170
(2S,3R)-2-[[(1S)-3-amino-1-[3-[(1R)-1-amino-2-hydroxyethyl]-1,2,4-oxadiazol-5-yl]-3-oxopropyl]carbamoylamino]-3-hydroxybutanoic acid
Molecular Identity
Ca-170
(2S,3R)-2-[[(1S)-3-amino-1-[3-[(1R)-1-amino-2-hydroxyethyl]-1,2,4-oxadiazol-5-yl]-3-oxopropyl]carbamoylamino]-3-hydroxybutanoic acid
PubChem CID: 126843231
2D Structure
Properties
C12H20N6O7
Molecular Formula
360.32
Molecular Weight
g/mol
360.1393
Exact Mass
Da
-6.7
XLogP
Drug-like (Lipinski: < 5)
227
TPSA
May have limited oral absorption
7
H-Bond Donors
10
H-Bond Acceptors
493
Complexity
SMILES
Canonical SMILES
SMILES: CC(C(C(=O)O)NC(=O)NC(CC(=O)N)C1=NC(=NO1)C(CO)N)OIsomeric SMILES
SMILES: C[C@H]([C@@H](C(=O)O)NC(=O)N[C@@H](CC(=O)N)C1=NC(=NO1)[C@H](CO)N)OSynonyms(20)
1673534-76-3CA-170Aurigene 1646MN6KQ16RefChem:1080600AUPM 170Ca 170PD-L1/PD-L2/VISTA Antagonist CA-170PD-L1/PD-L2/VISTA Checkpoint Antagonist CA-170PD-1-IN-1(2S,3R)-2-(3-((S)-3-Amino-1-(3-((R)-1-amino-2-hydroxyethyl)-1,2,4-oxadiazol-5-yl)-3-oxopropyl)ureido)-3-hydroxybutanoic acidCA 170 [WHO-DD]EX-A1918(2S,3R)-2-[[(1S)-3-amino-1-[3-[(1R)-1-amino-2-hydroxyethyl]-1,2,4-oxadiazol-5-yl]-3-oxopropyl]carbamoylamino]-3-hydroxybutanoic acid(((S)-3-amino-1-(3-((R)-1-amino-2-hydroxyethyl)-1,2,4-oxadiazol-5-yl)-3-oxopropyl)carbamoyl)-L-threonine
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Ca-170
Loading drug network...